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Objective The objectives of this study were to clarify the short-term effects of transforaminal epidural steroid 
injection (TFESI) for degenerative lumbar scoliosis combined with spinal stenosis (DLSS), and to extrapolate 
factors relating to the prognosis of treatment.
Method Th   irty-six patients with lumbar radicular pain from DLSS were enrolled. Subjects were randomly assigned 
to one of two groups (steroid or lidocaine group). We compared the eff  ect of pain suppression at 2, 4 and 12 weeks 
after the procedure between the two groups. Radiographic analysis included measurement of the Cobb’s angle, 
the upper endplate obliquities of L3 and L4, and maximal lateral olisthy between two adjacent lumbar vertebrae. 
Sagittal plane measurement included lumbar lordosis, and thoracolumbar kyphosis. Statistical analysis of both 
radiographic and clinical parameters along with treatment outcome was performed to determine any signifi  cant 
correlations between the two.
Results There were no significant differences in the demographic data, initial visual analogue scale (VAS) or 
Oswestry disability index (ODI) between the steroid group (n=17) and the lidocaine group (n=19). Two, 4, and 
12 weeks after injection VAS, ODI showed a signifi  cantly greater improvement in the steroid group compared to 
the lidocaine group (p<0.05). The radiographic and clinical parameters were not significantly correlated with 
treatment outcome.
Conclusion Our findings suggest that fluoroscopic transforaminal epidural steroid injections appear to be an 
effective non-surgical treatment option for patients with degenerative lumbar scoliosis combined with spinal 
stenosis (DLSS) and radicular pain. 
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INTRODUCTION
  Radicular pain occurs due to an ectopic discharge phy-
siologically generated in either the dorsal root or the 
dorsal root ganglion. An important cause of radicular 
pain is mechanical compression exerted by degenerative 
changes in the facet joint, the posterior longitudinal 
ligament or the herniated disc. Another cause is 
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chemical irritation produced by phospholipase A2 or 
substance P secreted from the prolapsed intervertebral 
disc. As a result, they contribute to pain mechanisms 
by triggering venous congestion and/or neural edema 
around the nerve root.
1-3 The pathogenesis of radicular 
pain caused by lumbar spi  nal stenosis is difficult to 
explain by a unique factor, beca  use it is associated with a 
variety of mechanisms, including infl  ammation, venous 
congestion, mechanical compression, and circulation 
disturbance.
4,5 Epidural steroid injections (ESIs) have 
been used for the treatment of radicular pain, although 
their success rate has been reported to vary between 
20 % and 100 %.
6 There are several possible reasons for 
such inconsistent results: (1) The treatment targeted 
a diverse range of symptoms, including pri  mary axial 
pain, primary radicular pain, and radiculopathy, which 
had been elicited by many different causes (e.g., disc 
hernia  tion, spinal stenosis, spondylolisthesis, and 
failed back surgery syndrome); (2) The authors applied 
an indiscriminate treatment, without distinguishing 
between several steroid injection methods (e.g., caudal 
approach, interla  minar approach, and transforaminal 
approach); and (3) Steroid injections were used in 
different doses, from different formulations and with 
different needle sizes.
7 In addition, their accuracy may 
be limited because the cited results were obtained from 
injection procedures performed blindly without using 
fluoroscopy control.
8 Moreover, there are only a few 
studies in the literature that compare diff  erent causes or 
diff  erent injection approaches when assessing the eff  ects 
of steroid injections for the treatment of radicular pain. 
This makes it more difficult to determine the specific 
injection treatment options required by individual 
patients, as well as their characteristics. 
  Unlike adolescent idiopathic scoliosis, degenerative 
lum    bar scoliosis is usually accompanied by spinal 
stenosis. Therefore, it becomes increasingly prevalent 
in the el  derly, which included population older than 
50 years of age.
9,10 Most patients with degenerative lum-
bar sco  liosis combined with spinal stenosis also pre  -
sent with other symptoms, such as neurogenic clau  di-
ca  tion, radiating pain, and/or axial back pain.
10-12 So 
far, epidural injections have not drawn much attention 
as an alternative appro  ach for the treatment of lumbar 
radicular pain caused by degenerative lumbar scoliosis 
combined with spinal stenosis. Simotas et al.
13 studied 
the eff  ects of epidural injections and other conservative 
treatments in patients with spinal stenosis and neurogenic 
claudication. They reported that the treatments were 
less effective in cases of combined scoliosis, as seen on 
radiographs. However, their study could not accurately 
assess the effects of epidural injections because it was 
performed in a small number of subjects (n=15) while 
receiving different additional conservative treatments. 
Cooper et al.
7 conducted a retrospective study to inve-
stigate the effects of transforaminal injections on the 
radiculopathy produced by degenerative lumbar scoliosis 
with spinal stenosis. Th   ey reported a successful treatment 
effect in 59.6 percent of the studied subjects at week 1 
of the injection, 55.8 percent at month 1, 37.2 percent at 
year 1, and 27.3 percent at year 2. 
  Th   e primary objective of this study was to prospectively 
examine the effects of transforaminal steroid injections 
on radicular pain elicited by degenerative lumbar 
scoliosis combined with spinal stenosis. In addition, 
we investigated the relationship between radiation in-
dicators of scoliosis and patient characteristics that could 
infl  uence the treatment eff  ects. 
MATERIALS AND METHODS
Subjects
  Th   e subjects of this study were aged 50 years and older 
and selected from patients who visited our hospital’s 
Department of Physical Medicine and Rehabilitation 
with complaints of radiating pain, between January 1, 
2009 and June 31, 2010. We took their history and per-
formed physical examination in all our patients. In the 
present study, inclusion criteria were as follows: 1) cases 
with pain that increased with lumbar extension and 
decreased with lumbar fl  exion; 2) patients with radiating 
pain present at least below the knee joint; and 3) cases 
with a thoracolumbar scoliosis greater than 10 degrees, 
visible on the standard Rx in the standing anterior-
posterior (AP) and lateral views of the whole spine, in-
cluding the hip joint and the cervical spine, or in the 
standing lateral bending views of the lumbar spine. Th  e 
subjects were patients who were found to have spinal 
stenosis on both CT and MRI examinations of the lumbar 
spine performed for the nerve-root location in those 
cases. Th   e exclusion criteria were as follows: 1) patients 
with any systemic inflammatory disease or diabetes; 2) Hee-Seung Nam and Yong Bum Park
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patients taking anticoagulant medication; 3) patients 
who had previously experienced side eff  ects from the use 
of lidocaine or contrast dye; 4) patients with any known 
or suspected infectious disease; 5) patients who found it 
diffi   cult to regularly visit the hospital because of general 
bad health; 6) patients with a skin disorder rending them 
unsuitable for injection administration on the injection 
site; 7) cases with a mental health problem who were un-
able to complete a questionnaire; 8) patients who had 
received a steroid injection in the three months prior to 
the beginning of the study; 9) cases with degenerative 
spondylolisthesis, osteoporosis or compression fracture; 
and 10) patients who had received surgical treatment of 
the thoracolumbar region or cases with cancer meta-
stasis to the thoracolumbar site or with spinal deformity 
caused by metabolic disease. Degenerative lumbar 
scoliosis patients were included in the study only when 
their radicular pain resulted from lateral foraminal 
ste  nosis. In contrast, patients with spinal stenosis or 
neurogenic claudicaiton were excluded from the study. 
We also excluded cases with neurological symptoms 
such as cauda equine syndrome, and patients that nee-
ded nonsteroidal anti-inflammatory drugs other than 
acetaminphen or low dose aspirin, as well as those who 
continued to receive other conservative treatments such 
as physiotherapy over the clinical trial period. Th  is  could 
influence the assessment of the overall curative value 
during the clinical period.
Assignment of subjects to the study groups 
The subjects were divided into two groups and treated 
with one of two diff  erent injection drugs. For the ste  roid 
group, the injection site was highlighted on the radio-
scopy with 1 cc of nonionic contrast (Omnipaque 300; 
GE Health care, Shanghai, Ireland) and a mixture of 1.5 
cc 0.5% lidocaine and 20 mg (0.5 cc) triamcinolone was 
administered. In the control group, 1 cc of nonionic 
contrast (Omnipaque 300) was injected to visualize the 
injection site and each subject received a transforaminal 
injection of 2 cc 0.5% lidocaine without triamcinolone. 
Block randomization was used to group the subjects and 
allocate them to each of the groups. With a block size of 
four for two arms (A and B), six possible combinations of 
blocks consisting of two As and two Bs were produced: 
AABB, ABAB, BAAB, BABA, BBAA, and ABBA. A random 
number sequence was used to select a particular block, 
thus determining the allocation order for the first four 
subjects. Similarly, the next four patients were allocated 
to the treatment group, in the order required by the next 
randomly selected block. 
Injection approaches and their eﬀ  ects 
  Th   e transforaminal approach: Each subject was placed 
in the prone position with a pillow under the abdomen to 
reduce lumbar lordosis. A Scotty dog image was used to 
identify the desired lumbar region. Th   e C-arm (KMC 950, 
KOMED, Kwangju, Kyunggi, Korea) was adjusted to align 
with the inferior endplate of the spine and rotated by 
15-30 degrees to an oblique view, so that the Scotty dog 
image became visible. Th   e target region was disinfected, 
and a 22-gauge 3.5-inch spinal needle (Spinocan
®, 
BRAUN, Melsungen, Germany) was used. To avoid the 
Fig.1. Fluoroscopically guided trans-
foraminal epidural injection. (A)  ante-
roposterior view, (B) lateral view.The Eﬀ  cts of Transforaminal Injection for DLSS
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nerve roots emerging from the spinal cord, the needle 
was advanced into either the right inferior aspect of the 
spinal pedicle or the inferolateral portion (safe triangle) 
of the pars interarticularis, towards the superior aspect of 
the intervertebral foramen. When the needle tip reached 
the inferolateral border, the C-arm was rotated to obtain 
lateral images. Then the needle was slowly advanced 
towards the anterosuperior aspect of the foramen. Once the 
needle was placed in the fi  nal position, a fi  ne aspiration 
was performed, to check for the presence of blood. One 
cc of nonionic contrast dye was administered under 
real-time fluoroscopic imaging to determine if the drug 
was injected into the anterior epidural space. After the 
administration of the contrast dye, anteroposterior and 
lateral radiographs were taken and a 2 cc dose of the drug 
solution was injected (Fig. 1). 
  Comparison of the injection effects between the two 
groups: Pain scores on the visual analogue scale (VAS) 
were recorded at baseline and at weeks 2, 4 and 12 
of treatment, for comparison of the treatment effects 
of injections. A 100-mm horizontal graded scale was 
presented to the patients. Pain was rated from no pain=0 
to the most severe pain=10, and the subjects were asked 
to indicate their pain on the scale. Th   e degrees of physical 
disability were measured using the Oswestry Disability 
Index (ODI). Physical disability was noted as percentage 
values, from no disability=0% to the most severe disability 
=100%. At week 12, the subjects were asked to rate their 
satisfaction with the treatment, as follows: “no residual 
pain (excellent),” “improvement of pain symptoms by 
more than 50% (good),” “improvement of pain symptoms 
by less than 50% (fair),” or “no improvement of pain 
(poor).” Reponses of “excellent” and “good” were consi-
dered to represent pain relief. 
  Injection frequency and time intervals: Two weeks 
after the first injection treatment, during the outpatient 
visit, if satisfaction with the treatment was rated as “no 
improvement of pain (poor)” or there was no change in 
the VAS and ODI scores, the patients were excluded from 
the study. However, one more injection was given one 
week thereafter, if there was only partial eff  ect in cases of 
“improvement of pain symptoms by less than 50% (fair)” 
in treatment satisfaction, less than 50% in the VAS, and 
less than 30% in the ODI. Th   e cases of more than 50% in 
the VAS, more than 30% in the ODI, as well as no residual 
pain (excellent) and improvement of pain symptoms by 
more than 50% (good) in treatment satisfaction were just 
followed up without additional injection. 
Correlations of the treatment effects with different 
factors 
  Th   e treatment was successful when the patients rated their 
satisfaction level as “no residual pain” or “improvement 
of pain symptoms by more than 50%” 12 weeks after 
the first injection treatment and when they showed an 
improvement of more 40% in the VAS and an impro-
vement of more than 20% in the ODI at the same point 
in time. The study examined the correlations between 
these measurements and the patients’ age, pain duration, 
sex, or pre-injection radiation indicator of degenerative 
lumbar scoliosis. For the radiological analysis, we took 
the standing AP and lateral views of the whole spine, 
including the hip joint and cervical spine, and both 
lateral bending views of the lumbar spine, using a 14×36-
inch cassette. Then we measured the lumbar spine 
scoliosis angle with the Cobb angle method and the axial 
rotation angle of the spinal body with the method of 
Nash and Moe
14 for the measurement of spinal rotation. 
The lateral shift and the L3 and L4 endplate obliquity 
angles were measured using the method of Schwab et 
al.
15 In addition, from the lateral views, we measured the 
lordosis angle between the upper margin of L1 and the 
upper margin of S1, and the thoracolumbar kyphosis 
angle between the upper margin of T11 and the lower 
margin of L1. 
Statistical analysis 
  Th   e chi-square test and Wilcoxon’s rank sum test were 
used to compare the two investigated groups in terms 
of age, sex, body mass index, pain duration, injection 
frequency, and radiation indicators. The independent 
t-test was conducted to compare the ODI and the VAS 
scores differences between the two groups, at each 
treat  ment time point. A repeated measures analysis of 
variance (ANOVA) was used to assess the injection eff  ects 
over time, and the Bonferroni’s correction was applied 
for post hoc tests. In determining the treatment effects, 
the chi-square test was used to compare the diff  erences 
between the two groups, in terms of success rate and 
patient satisfaction index. A logistic regression analysis 
was employed to examine the correlations between the 
post-injection clinical results and the patients’ age, pain Hee-Seung Nam and Yong Bum Park
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duration, sex, or radiation indicators of degenerative 
lumbar scoliosis. Data was statistically analyzed with 
a significance level of p≤0.05 using the SAS Enterprise 
Guide version 4.1 (4.1.0.471) software. 
RESULTS
General characteristics 
  This study included a total number of 36 subjects who 
were divided into two groups: the steroid injection 
group (n=17, mean age=75.24±5.27 years) and the 
lidocaine injection group (n=19, mean age=71.58±9.55 
years). There was no statistically significant difference 
between the two groups in the following measurements: 
male-female ratio, body mass index, pain duration, 
and injection frequency. There was also no statistically 
significant difference in the causes of the nerve root 
stenosis, as seen on both thoracolumbar spine MRI and 
CT scans (Table 1, 2).
Patient ﬂ  ow 
  A total number of 61 patients were enrolled, whereas 
13 dropped out of the study according to the exclusion 
criteria. One subject in the steroid group and two subjects 
in the lidocaine group were excluded from the study 
because they showed no effect during the follow-up. In 
the middle of the study, two subjects in the steroid group 
and one subject in the lidocaine group were transferred 
to a diff  erent medical department for surgical treatment. 
We eliminated two patients from the lidocaine group 
for taking an anti-inflammatory drug different from 
acetaminophen during the study. Four other patients 
were excluded halfway because it became difficult for 
them to regularly visit the hospital. 
Table1. Comparison of Steroid and Lidocaine Patient 
Groups
Steroid group 
(n=17)
Lidocaine 
group (n=19)
p-value 
Female 13(76.5%) 14 (73.7%) 0.847
Age (years) 75.24±5.27 71.58±9.55 0.349
Pain duration (mo)   7.71±2.59   6.74±2.83 0.201
BMI (kg/m
2) 23.37±2.55 22.95±1.75 0.409
Number of 
  patients with
  1 injection
8 (42.1%) 11 (57.9%)
Number of 
  patients with
  2 injection
9 (52.9%) 8 (47.1%) 0.376
Number of
  S1 injection
2 (11.7%) 3 (15.8%)
Number of
  L5-S1 injection
6 (35.4%) 8 (42.1%)
Number of
  L4-5 injection
7 (41.2%) 7 (36.8%)
Number of
  L3-4 injection
2 (11.7%) 1 (5.3%) 0.275
Values are shown as mean±standard deviation
BMI: Body mass index
Statistical significance between the two groups, calcu-
lated using Wilcoxon’s rank sum test or Chi-square test 
*p<0.05
Table 2. Comparison of Steroid and Lidocaine Groups in 
Radiologic Findings
Steroid 
group (n=17)
Lidocaine 
group (n=19)
p-value
Cobb’s angle 16,79±6.81 15.14±3.44 0.751
Lateral olisthesis
  (mm)
  5.42±2.11     5.35±2.12 0.975
Endplate 
  obliquities of
  L3 angle
  8.49±4.72   8.18±4.43 0.775
Endplate 
  obliquities of
  L4 angle
  8.31±4.57   9.18±3.96 0.505
Th  oracolumbar 
  kyphosis
  8.36±4.79   8.34±4.45 0.924
Lordosis angle 33.37±8.51 32.12±6.41 0.680
Vertebral rotation 
  grade (Neutral/I/
  II/III/IV)
n=17 
(4/10/1/1/1)
n=19 
(4/12/1/1/1)
0.999
Radiologic fi  nding
Hypertrophic facet 
  osteoarthritis
5  6
Pedicular kinking  8 10
Posterolateral 
  verterbral body 
  spur
3  2
Subluxation of
  superior facet
1   1   0.254
Values are shown as mean±standard deviation
Statistical significance between the two groups, calcu-
lated using Wilcoxon’s rank sum test or Chi-square test 
*p<0.05The Eﬀ  cts of Transforaminal Injection for DLSS
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Comparison of the treatment eﬀ  ects 
  At baseline, there was no difference between the two 
groups in the ODI and VAS scores. However, at weeks 2, 4 
and 12 of treatment, the steroid group showed signifi  cant 
improvements compared to the lidocaine group (Fig. 2, 3). 
For treatment eff  ectiveness over time after the injection 
procedure, both groups showed a significant decrease 
in the VAS score compared to baseline. This effect was 
maintained until weeks 2, 4 and 12 after ini  tiation of 
treatment (Fig. 2). The ODI also significantly improved 
in both groups, compared to baseline. Th  e  improvement 
was continued until weeks 2, 4 and 12, as well (Fig. 3). At 
week 12, the treatment eff  ect was assessed as successful 
in 13 steroid group subjects and 8 lidocaine group 
subjects. Consequently, the steroid group achieved a 
statistically higher success rate than the lidocaine group. 
Patient satisfaction also rated signifi  cantly higher in the 
steroid group (p<0.05). 
Treatment eﬀ  ects and correlations between the patient 
factors and the radiation indicators 
Treatment success was defined as an improvement of 
more than 40% in the VAS score and more than 20% in 
the ODI score, as well as the patient satisfaction level of 
“no residual pain (excellent)” or “improvement of pain 
symptoms by more than 50% (good),” at week 12 after 
the injection treatment. In the analysis based on this 
defi  nition, we found no correlation between the patient 
factors and radiation indicators (Table 3). 
DISCUSSION
  Degenerative lumbar scoliosis is usually accompanied by 
axial back pain and spinal stenosis. Unlike the common 
symptoms of spinal stenosis, axial back pain is persistent 
when sitting and at rest.
16 It is known that radiating pain 
is mostly caused by nerve compression resulting from 
foraminal stenosis, which, is caused by the contact of the 
facet joint after the intervertebral disc collapses from disc 
herniation, and from lateral reposition of the vertebral 
body.
17-19 Except for this mechanical compression, the 
causes for radicular pain of spinal stenosis produced by 
degenerative lumbar scoliosis cannot be explained by a 
unique theory. Th   erefore, the radicular pain is associated 
with various mechanisms, such as infl  ammatory changes 
around the nerve roots, venous congestion, or circulation 
disturbance.
4,5 When injected into the human body, 
steroids ease pain by inhibiting prostaglandin synthesis, 
blocking the conduction of nociceptive C-fibers, and 
con  trolling the edema around nerve roots.
20-22 For this 
reason steroid injections are used in patients diagnosed 
with radicular pain elicited by spinal stenosis. 
  To date, there are only few studies on epidural steroid 
injections in patients with spinal stenosis. Hoogmartens 
and Morelle
23 performed epidural steroid injections 
blindly (without radioscopy control), using the caudal 
approach, and reported the following treatment eff  ects: 
32% good, 16% average, and 52% bad. In the retrospective 
study conducted by Rosen et al.,
24 steroids were injected 
without radioscopy control with the interlaminar ap-
Fig. 2. Comparative response from VAS pre-injection, 2 weeks, 
1 month, 3 months for steroid group and lidocaine group. 
*statistically signifi  cant at p<0.05 within groups, 
#statistically 
signifi  cant at p<0.05 within intergroup. VAS: Visual analogue 
scale, S: Steroid group, L: Lidocaine group.
Fig. 3. Comparative response from ODI pre-injection, 2 
weeks, 1 month, 3 months for steroid group and lidocaine 
group. *statistically significant at p<0.05 within groups, 
#statistically significant at p<0.05 within intergroup. ODI:   
Oswestry disability index, S: Steroid group, L: Lidocaine 
group.Hee-Seung Nam and Yong Bum Park
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pro  ach. Pain relief was reported in 66% of the patients 
at 2 months and in 25% of the patients 8 months after 
initiation of treatment. Th   ese studies were conducted in a 
blind interlaminar or caudal approach without the aid of 
an image-enhancing device. Therefore, they have some 
clear limitations with regards to the accuracy of injection. 
It is impossible to target a specifi  c lesion region without 
visual control. It has been demonstrated that blind 
epidural steroid injections, even done by very skilled 
doctors, showed over 25% probability for the needle to 
be improperly positioned.
7 In the study conducted by 
Delport et al.
25 using an image-enhancing device instead 
of the blind procedure, after steroid was injected with 
the caudal and interlaminar approaches, one third of 
the patients demonstrated pain relief and about half of 
them showed some improvement. In addition, Riew et 
al.
26 conducted a prospective, randomized, double-blind 
study and reported that when transforaminal steroid 
injections were given in spinal stenosis patients using the 
C-arm, some clinical improvement was found during the 
follow-up period of 15-28 months. Coo per et al.
7 conducted 
a retrospective study on the effects of transforaminal 
steroid injections performed using the C-arm to treat the 
radiculopathy produced by degenerative lumbar scoliosis 
combined with spinal stenosis. They reported that at 
year 2 after injection, successful treatment effects were 
found in 27.3% of the patients. Th   erefore, they concluded 
that this procedure can be selected as one of the elective 
non-surgical treatment methods. However, these studies 
were all retrospective and not conducted within the same 
patient group. Besides, several methods were attempted 
for an epidural approach. In addition, the way of chec-
king for the injection eff  ects showed such limitation that 
it could not discriminate the axial back pain from the 
radicular pain. Using the prospective randomization 
design, this study used the lidocaine injection group 
as a control group. Then we investigated the effects 
of transforaminal epidural injections performed with 
the C-arm. Compared with the lidocaine group, the 
transforaminal epidural injections were statistically more 
eff  ective, as measured by the VAS score and the functional 
rating index. Furthermore, during the 3-month follow-up 
period, continuous improvement was found. This effect 
of the steroid injections on the radicular pain produced 
by spinal stenosis may be explained by the fact that an 
infl  ammatory reaction by compression is associated with 
the direct cause for pain, which is mechanical com pression. 
Steroid injections not only reduce the inflammatory 
reaction, but also block nerve conduction via nociceptive 
C fibers, thus suppressing the direct pain pathway, and 
further relieving the symptoms.
27 
  Simotas et al.
13 examined correlations between the ef-
fects of non-surgical treatment and several factors in 
patients with spinal stenosis. They reported that the 
treatment eff  ects decreased in patients with scoliosis or 
in old patients. Miyamoto et al.
28 also reported that the 
treatment eff  ects decreased in patients with scoliosis, but 
they found no correlation with age. Th   is study examined 
correlations between the treatment effects and several 
factors, including age, gender, body fat per  centage 
disease duration, and the radiation indicators of scoliosis, 
which were divided into thoracolumbar ky  phosis, lordosis, 
and the Cobbs angle method. As a result, no correlations 
with the indicators were found. The study by Miyamoto 
et al.
28 did not divide its subjects into a group of central 
stenosis patients with neurogenic claudication and a 
group of lateral stenosis patients with radicular pain, 
and the subjects did not receive the same treatment. We 
consider this as a limitation of the study. We consider 
that without a good understanding of the causes of pain, 
such as radicular pain produced by lateral stenosis, the 
referred pain elicited by facet joint syndrome, visceral 
Table 3. Multiple Logistic Regression Analysis for Possible 
Outcome Predictors for Injection Eff  ectiveness at Short-
term Follow-up
Factor OR 95% CI p-value
SEX 0.706     0.49-10.188 0.798
Age (years) 0.869 0.726-1.041 0.127
BMI (kg/m
2) 0.833 0.515-1.346 0.456
Duration 1.062 0.708-1.593 0.772
Cobb’s angle 0.988 0.752-1.299 0.934
Th  oracolumbar  kyphosis 0.962 0.752-1.232 0.761
Lordosis 1.071 0.930-1.234 0.338
Lateral olisthesis 1.635 0.638-4.191 0.306
Endplate obliquities of
  L3 angle
1.061      0.80-1.394 0.674
Endplate obliquities of
  L3 angle
0.688 0.444-1.068 0.096
OR: Odds ratio, 95% CI: 95% Confidence interval, BMI: 
Body mass index
p<0.05The Eﬀ  cts of Transforaminal Injection for DLSS
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pain, muscle pain, or lumbar sprain, suitable treatment 
for diagnosis cannot be given. It may also be diffi   cult to 
know adequate treatment effects and further, the cor-
relations with several factors. In this study, patients with 
degenerative lumbar scoliosis were included only when 
they had radicular pain produced by lateral stenosis. 
Th   ey were excluded when they had central stenosis, such 
as neurogenic claudication. In relation to the treatment 
methods, only the transforaminal injection treatment 
using the C-arm was given and during the trial, patients 
who took medicine influencing the treatment effects 
and the conservative treatment were excluded. Thus, 
the reliability of the study results increased. Cases of 
degenerative lumbar scoliosis are usually accompanied 
by severe back pain in addition to lateral stenosis. van 
Dam
29 showed that such back pain resulted mostly from 
the surrounding muscles, intervertebral disc and facet 
joint. Pritchett and Bortel
30 reported that it was associated 
with the reduction of the lordotic angle. Ac  cording to 
the study by Schwab et al.,
15 in the case of adult patients 
with scoliosis, pain correlated with radiation indicators, 
and was especially highly associated with the L3 and L4 
scoliosis angles, lateral displacement, reduced lumbar 
lordosis and thoracolumbar kyphotic angle. Accor-
dingly, symptoms of severe back pain, radiating pain, 
and spinal instability appeared in patients with de  ge-
nerative lumbar scoliosis. After ending the clinical trials, 
we performed a lumbar medial branch block in seven 
patients with combined back pain, and some of them 
showed improvement. In addition to radicular pain 
caused by spinal stenosis, patients with degenerative 
lumbar scoliosis could have back pain due to several 
reasons, hence they may need treatment for it. Th  is  study 
found no correlations between the treatment effects on 
radicular pain and the radiation indicators of patients 
with degenerative lumbar scoliosis. However, referring 
to the results of the studies described above, it was 
considered that radiation indicators are associated with 
back pain. In future work, it will be necessary to study the 
correlations between the lumbago-related medial branch 
blocks for the back pain of lumbar scoliosis patients, 
and conservative treatment results for visceral pain, as 
well as the radiation indicators mentioned above. In the 
assessment of the treatment eff  ects done over 12 weeks, 
the success rate was 76.5% in the steroid group and 
42.1% in the lidocaine group. In the study by Cooper et 
al.
7 the criteria for successful treatment included patient 
satisfaction index of grades 1-2 and the numeric pain 
rating of grade 2 or higher. In the study by Ng et al.
31 20 
mm reduction in the visual analogous scale and 10% 
reduction in the ODI score were found. Compared with 
those studies, this study judged success or failure based 
on stricter criteria (“no residual pain” and “improvement 
of pain symptoms by more than 50%” as patient sati-
sfaction index, and 40% VAS and over 20% ODI im  pro-
ve  ment). Therefore, we considered the assessment of 
our results as reliable. Patients who failed conservative 
treatment could require surgical treatment. Indications 
of absolute surgical treatment included neurological 
symptoms like cauda equine syndrome and severe 
pain that did not respond to conservative treatment.
11,12 
However, most lumbar scoliosis patients are quite old 
and have cardio pulmonary or heart diseases. They 
also have severe degenerative deformity of the spine, 
so it is difficult for them to receive surgery.
32 In cases 
of accompanying degenerative neurological disorders, 
like Alzheimer’s disease or Parkinson’s disease, it is 
very diffi   cult to apply rehabilitation treatment after sur-
gery.
33 Some of the previous studies reported that a key 
to success of non-surgical treatment for patients with 
spinal stenosis was an intensive and aggressive initial 
treatment.
13,34,35 In particular, Miyamoto et al.
28 judged 
the hospitalization treatment of 2-3 weeks as an intensive 
treatment method and reported that a combination of 
various non-surgical treatments during this period, like 
physiotherapy and brace or orthosis wearing, could have 
synergistic effects. In addition, steroid injections deli-
vered with various approaches could be applied during 
this intensive treatment period. They suggested that 
this intensive hospitalization treatment could become 
an intermediate step between outpatient treatment 
and surgical treatment.
28 Therefore, future studies of 
degenerative lumbar scoliosis patients with spinal ste-
nosis are required to cover outpatient, inpatient and 
surgical treatments.
  In this study, the lidocaine group showed 42.1% treat-
ment success. In relation to the post-injection treatment 
eff  ects, both VAS and ODI scores statistically decreased, 
compared with the pre-injection state. According to the 
study by Lahat et al.
36 lidocaine reduces generation of 
the nuclear factor-kappa B (NF-kB), which is an intra-
cellular signaling protein. In addition it suppresses the 
pro  life  ration of T-cells, which are involved in immunity 
and inflammatory reaction, as well as the generation of Hee-Seung Nam and Yong Bum Park
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se  veral cytokines, which generate the anti-infl  ammatory 
reaction. A study using a rat model of septic peritonitis 
reported that lidocaine injections reduced concentrations 
of the TNFα and the keratinocyte-derived chemokine 
(KC), which are cytokines involved in the plasma infl  am-
matory reactions.
37,38 
  It was also reported that lidocaine suppresses the secre-
tion of histamine, which is a vehicle of the infl  ammatory 
reaction, from mast cells and also reduces the release of 
leukotrien B-4 and interleukin 1 from both mononuclear 
and multinucleated cells.
39 In addition to the anti-infl  a-
mmatory reaction, lidocaine works on sodium channels 
to block the nociceptive pain pathway and nerve con-
duction via the spinal dorsal root ganglion, thus further 
relieving pain.
40 Therefore, lidocaine injections can 
eli  cit pain relief effects by blocking pain transmission 
and by affecting the inflammatory reaction and many 
intracellular signaling proteins. 
  Although conducted in a prospective randomized 
design, this study had some limitations. One was that it 
failed to remove the bias that may occur when assessing 
the outcome of the patient treatment using a double-
blinded method. Other limitations included a very small 
number of subjects, as well as not determining a long-
term curative value. Moreover, the study targeted only the 
radicular pain cases among patients with degenerative 
lumbar scoliosis combined with spinal stenosis. This 
made us unaware of the treatment effects for back 
pain and neurogenic claudication. Further studies are 
required to elucidate such eff  ects.
CONCLUSION
  For patients with degenerative lumbar scoliosis com-
bined with spinal stenosis, steroid injections for radicular 
pain achieved effective pain relief for three months, 
compared to lidocaine injections. The transforaminal 
steroid injection approach can be considered a valid non-
surgical treatment option for radicular pain in patients 
diagnosed with degenerative lumbar scoliosis. 
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